Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?

被引:2
|
作者
Tomita, Toshihiko [1 ]
Miwa, Hiroto [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Upper Gastroenterol, Kobe, Hyogo, Japan
关键词
ACID SUPPRESSANTS; OMEPRAZOLE;
D O I
10.5056/jnm.2011.17.4.434
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:434 / 434
页数:1
相关论文
共 50 条
  • [1] Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
    Nonaka, Takashi
    Inamori, Masahiko
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 17 (04) : 435 - 435
  • [2] Concerning Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists
    Xie, Jian
    Li, Lang
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10):
  • [3] Concerning Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists Reply
    Pereg, David
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10):
  • [4] Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and the Risk of Kidney Stones: Negligible or Not?
    Pella, Eva
    Chalkidou, Maria
    Sarafidis, Pantelis
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (03) : 624 - 625
  • [5] Histamine 2 Receptor Antagonists and Proton Pump Inhibitors
    Brinkworth, Megan D.
    Aouthmany, Mouhammad
    Sheehan, Michael
    DERMATITIS, 2016, 27 (03) : 100 - 109
  • [6] Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Liu, Peipei
    McMenamin, Una
    Johnston, Brian
    Murchie, Peter
    Iversen, Lisa
    Lee, Amanda
    Vissers, Pauline
    Cardwell, Christopher
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 45 - 45
  • [7] Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Peipei Liu
    Úna C. McMenamin
    Brian T. Johnston
    Peter Murchie
    Lisa Iversen
    Amanda J. Lee
    Pauline A. J. Vissers
    Chris R. Cardwell
    British Journal of Cancer, 2020, 123 : 307 - 315
  • [8] Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Liu, Peipei
    McMenamin, Una C.
    Johnston, Brian T.
    Murchie, Peter
    Iversen, Lisa
    Lee, Amanda J.
    Vissers, Pauline A. J.
    Cardwell, Chris R.
    BRITISH JOURNAL OF CANCER, 2020, 123 (02) : 307 - 315
  • [9] Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis
    Vangala, Chandan
    Niu, Jingbo
    Lenihan, Colin R.
    Mitch, William E.
    Navaneethan, Sankar D.
    Winkelmayer, Wolfgang C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1534 - 1541
  • [10] Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
    Kweon, Takhyeon
    Kim, Yerim
    Lee, Kyung Joo
    Seo, Won-Woo
    Seo, Seung In
    Shin, Woon Geon
    Shin, Dong Ho
    SCIENTIFIC REPORTS, 2023, 13 (01):